Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice

This publication has 62 references indexed in Scilit:

• MEPE has the properties of an osteoblastic phosphatonin and minhibin
  Bone, 2004
• Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein
  Biochemical Journal, 2003
• Developmental regulation of the growth plate
  Nature, 2003
• Osteomalacia in Hyp Mice Is Associated with Abnormal Phex Expression and with Altered Bone Matrix Protein Expression and Deposition
  Endocrinology, 2001
• Identification of a Novel Fibroblast Growth Factor, FGF-23, Preferentially Expressed in the Ventrolateral Thalamic Nucleus of the Brain
  Biochemical and Biophysical Research Communications, 2000
• Pex Gene Deletions in Gy and Hyp Mice Provide Mouse Models for X-Linked Hypophosphatemia
  Human Molecular Genetics, 1997
• Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure
  American Journal of Kidney Diseases, 1997
• Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
  New England Journal of Medicine, 1986
• The Prevalence of Bone Aluminum Deposition in Renal Osteodystrophy and Its Relation to the Response to Calcitriol Therapy
  New England Journal of Medicine, 1982
• Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S
  Teratology, 1980